Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL™ Nausea Relief
Posted 03:20:00 12/17/2014 by Admin
LAS VEGAS, Dec. 17, 2014 /PRNewswire/ -- Oasis Health Products, Inc. announced today the completion of stability testing on Itonis, Inc.'s EMESYL™ Nausea Relief product and its scheduled release on December 19, 2014.
Oasis Health Products, a wholly owned subsidiary of Migranade, Inc. has confirmed that it has completed stability testing on EMESYL™ Nausea Relief giving the product an initial shelf life of 2 years.
"Now that the stability tests have been completed, we have scheduled a December 19th release date for the product," said Darren Krein, Oasis's Chief Executive Officer. "We are excited about EMESYL™ Nausea Relief as we expect it to be a big profit center for the company going forward."
ABOUT OASIS HEALTH PRODUCTS, INC.
Oasis Health Products, an FDA inspected, GMP facility, is one of the few manufacturers capable of producing high quality homeopathic medicines. Oasis provides formula & product development and manufacturing, advice, guidance, and contacts in areas such as sales, distribution, logistics, marketing, warehousing, etc.
For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oasis-health-products-inc-announces-completion-of-stability-testing-on-itonis-incs-emesyl-nausea-relief-300011565.html
SOURCE Oasis Health Products, Inc.
Stock Quote - ITNS
Investor RelationsItonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.
Contact our office at (949) 200-8887 or email us at email@example.com for more information.
Latest Quarterly Reporthttp://www.otcmarkets.com/financialReportViewer?symbol=ITNS&id=180805